Literature DB >> 7732026

Differential activation of proliferation and cytotoxicity in human T-cell lymphotropic virus type I Tax-specific CD8 T cells by an altered peptide ligand.

P Höllsberg1, W E Weber, F Dangond, V Batra, A Sette, D A Hafler.   

Abstract

Human T-cell leukemia virus type I (HTLV-I) gives rise to a neurologic disease known as HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Although the pathogenesis of the disease is unknown, the presence of a remarkably high frequency of Tax-specific, cytotoxic CD8 T cells may suggest a role of these cells in the development of HAM/TSP. Antigen-mediated signaling in a CD8 T-cell clone specific for the Tax(11-19) peptide of HTLV-I was studied using analog peptides substituted in their T-cell receptor contact residues defined by x-ray crystallographic data of the Tax(11-19) peptide in the groove of HLA-A2. CD8 T-cell stimulation with the wild-type peptide antigen led to activation of p56lck kinase activity, interleukin 2 secretion, cytotoxicity, and clonal expansion. A Tax analog peptide with an alanine substitution of the T-cell receptor contact residue tyrosine-15 induced T-cell-mediated cytolysis without activation of interleukin 2 secretion or proliferation. Induction of p56lck kinase activity correlated with T-cell-mediated cytotoxicity, whereas interleukin 2 secretion correlated with [3H]thymidine incorporation and proliferation. Moreover, Tax peptide analogs that activated the tyrosine kinase activity of p56lck could induce unresponsiveness to secondary stimulation with the wild-type peptide. These observations show that a single amino acid substitution in a T-cell receptor contact residue of Tax can differentially signal CD8 T cells and further demonstrate that primary activation has functional consequences for the secondary response of at least some Tax-specific CD8 T cells to HTLV-I-infected target cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7732026      PMCID: PMC42097          DOI: 10.1073/pnas.92.9.4036

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  The antigenic identity of peptide-MHC complexes: a comparison of the conformations of five viral peptides presented by HLA-A2.

Authors:  D R Madden; D N Garboczi; D C Wiley
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

2.  Separation of T helper 1 clone cytolysis from proliferation and lymphokine production using analog peptides.

Authors:  B D Evavold; J Sloan-Lancaster; B L Hsu; P M Allen
Journal:  J Immunol       Date:  1993-04-15       Impact factor: 5.422

Review 3.  MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation.

Authors:  R N Germain
Journal:  Cell       Date:  1994-01-28       Impact factor: 41.582

4.  Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules.

Authors:  J Ruppert; J Sidney; E Celis; R T Kubo; H M Grey; A Sette
Journal:  Cell       Date:  1993-09-10       Impact factor: 41.582

5.  Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells.

Authors:  J Sloan-Lancaster; B D Evavold; P M Allen
Journal:  Nature       Date:  1993-05-13       Impact factor: 49.962

6.  Characterization of MHC class I restricted cytotoxic T cell responses to tax in HTLV-1 infected patients with neurologic disease.

Authors:  S Koenig; R M Woods; Y A Brewah; A J Newell; G M Jones; E Boone; J W Adelsberger; M W Baseler; S M Robinson; S Jacobson
Journal:  J Immunol       Date:  1993-10-01       Impact factor: 5.422

7.  Effect of T-cell receptor antagonism on interaction between T cells and antigen-presenting cells and on T-cell signaling events.

Authors:  J Ruppert; J Alexander; K Snoke; M Coggeshall; E Herbert; D McKenzie; H M Grey; A Sette
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

Review 8.  src-related protein tyrosine kinases and their surface receptors.

Authors:  C E Rudd; O Janssen; K V Prasad; M Raab; A da Silva; J C Telfer; M Yamamoto
Journal:  Biochim Biophys Acta       Date:  1993-08-23

9.  Clone-specific T cell receptor antagonists of major histocompatibility complex class I-restricted cytotoxic T cells.

Authors:  S C Jameson; F R Carbone; M J Bevan
Journal:  J Exp Med       Date:  1993-06-01       Impact factor: 14.307

10.  High human T cell lymphotropic virus type 1 (HTLV-1)-specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-1-associated neurological disease.

Authors:  I Elovaara; S Koenig; A Y Brewah; R M Woods; T Lehky; S Jacobson
Journal:  J Exp Med       Date:  1993-06-01       Impact factor: 14.307

View more
  10 in total

Review 1.  Mechanisms of T-cell activation by human T-cell lymphotropic virus type I.

Authors:  P Höllsberg
Journal:  Microbiol Mol Biol Rev       Date:  1999-06       Impact factor: 11.056

2.  Phenotypic and functional evaluation of CD3+CD4-CD8- T cells in human CD8 immunodeficiency.

Authors:  Iván Bernardo; Esther Mancebo; Ignacio Aguiló; Alberto Anel; Luis M Allende; Juan M Guerra-Vales; Jesús Ruiz-Contreras; Antonio Serrano; Paloma Talayero; Oscar de la Calle; Cecilia Gonzalez-Santesteban; Estela Paz-Artal
Journal:  Haematologica       Date:  2011-05-05       Impact factor: 9.941

Review 3.  Immunological self/nonself discrimination: integration of self vs nonself during cognate T cell interactions with antigen-presenting cells.

Authors:  M D Mannie
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

4.  Partial signaling by CD8+ T cells in response to antagonist ligands.

Authors:  C Reis e Sousa; E H Levine; R N Germain
Journal:  J Exp Med       Date:  1996-07-01       Impact factor: 14.307

5.  An Altered gp100 Peptide Ligand with Decreased Binding by TCR and CD8α Dissects T Cell Cytotoxicity from Production of Cytokines and Activation of NFAT.

Authors:  Niels Schaft; Miriam Coccoris; Joost Drexhage; Christiaan Knoop; I Jolanda M de Vries; Gosse J Adema; Reno Debets
Journal:  Front Immunol       Date:  2013-09-04       Impact factor: 7.561

6.  Self-tolerance to the murine homologue of a tyrosinase-derived melanoma antigen: implications for tumor immunotherapy.

Authors:  T A Colella; T N Bullock; L B Russell; D W Mullins; W W Overwijk; C J Luckey; R A Pierce; N P Restifo; V H Engelhard
Journal:  J Exp Med       Date:  2000-04-03       Impact factor: 14.307

7.  Molecular mimicry of human cytochrome P450 by hepatitis C virus at the level of cytotoxic T cell recognition.

Authors:  A R Kammer; S H van der Burg; B Grabscheid; I P Hunziker; K M Kwappenberg; J Reichen; C J Melief; A Cerny
Journal:  J Exp Med       Date:  1999-07-19       Impact factor: 14.307

8.  Incomplete CD8(+) T lymphocyte differentiation as a mechanism for subdominant cytotoxic T lymphocyte responses to a viral antigen.

Authors:  J V Spencer; T J Braciale
Journal:  J Exp Med       Date:  2000-05-15       Impact factor: 14.307

Review 9.  On Peptides and Altered Peptide Ligands: From Origin, Mode of Action and Design to Clinical Application (Immunotherapy).

Authors:  Martín Candia; Bernhard Kratzer; Winfried F Pickl
Journal:  Int Arch Allergy Immunol       Date:  2016-09-20       Impact factor: 2.749

10.  Allelic variation of MHC structure alters peptide ligands to induce atypical partial agonistic CD8+ T cell function.

Authors:  Dong-Gyun Lim; Jacqueline M Slavik; Katarzyna Bourcier; Kathrine J Smith; David A Hafler
Journal:  J Exp Med       Date:  2003-07-07       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.